J&J Skin Care Sales Up 17% In Q1 Fueled By Neutrogena, Aveeno

Johnson & Johnson skin care sales increased 17% in the first quarter, fueled by the continued strength of Neutrogena and Aveeno, VP-Investor Relations Helen Short reported in an April 15 sales and earnings presentation. Sales increased 11% operationally and benefited 6% from positive currency effect, she said